Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration

Clinical trial NCT02222207 · TERMINATED

Trial details

NCT number: NCT02222207
Sponsor: Bayer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Macular Degeneration

Start date: 2014-10-01
Primary completion: 2015-05-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.